YATHARTH · Healthcare · Medical Care Facilities
Composite scorecard: 50/100 — Quality 60 · Valuation 14 · Momentum 89
| Share price | ₹848.90 |
| Market cap | ₹7,995 Cr |
| P/E ratio | 45.7 |
| P/B ratio | 4.7 |
| ROCE | 11.0% |
| Book value | ₹175.25 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹1,207 Cr | ₹170 Cr | 24.0% |
| 2025 | ₹860 Cr | ₹131 Cr | 26.0% |
| 2024 | ₹635 Cr | ₹114 Cr | 29.0% |
| 2023 | ₹478 Cr | ₹66 Cr | 28.0% |
| 2022 | ₹375 Cr | ₹44 Cr | 30.0% |
Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surgery and liver transplant, robotic surgery, kidney tr